Birth Defects
AI:n luoma kuva
Study warns that global use of valproate in pregnancy risk zones remains high
Raportoinut AI AI:n luoma kuva Faktatarkistettu
An international study across 73 countries finds that access to antiseizure medicines is improving, especially in low- and middle-income nations, but warns that valproate — a World Health Organization-listed essential medicine linked to serious birth defects when used in pregnancy — remains widely used. Researchers led by Aston University report uneven progress in safe prescribing between 2012 and 2022 and call for stronger safeguards for women of childbearing age.